Tetrazole Derivatives as Multiclass Inhibitors of Bacterial Carbonic Anhydrases
- 26 December 2025
- journal article
- Published by Wiley in Archiv der Pharmazie
- Vol. 358 (12) , e70177
Abstract
This study investigates derivatives including a tetrazole zinc‐binding group as inhibitors of the α‐, β‐, and γ‐class carbonic anhydrase (CA) isoforms from pathogenic bacteria such as Vibrio cholerae , Escherichia coli , and Streptococcus mutans . A library of 22 previously synthesized compounds was evaluated for their inhibitory activity against bacterial CAs using a stopped‐flow CO 2 hydrase assay. The tetrazole‐based inhibitors displayed marked activity toward bacterial α‐ and β‐class CAs, with inhibition constants ( K I s) ranging from 0.43 to 18.7 µM. Among them, 2i and 2p emerged as two of the most potent inhibitors. Selectivity studies showed that only a few compounds exhibited moderate (10‐ to 20‐fold) selectivity for bacterial β‐CAs over human CA I, with limited selectivity against human CA II. Molecular modelling studies of the most representative compounds elucidated the key interactions responsible for their potency and selectivity, in agreement with experimental findings. Overall, these results highlight tetrazole derivatives as promising scaffolds for the development of novel antibacterial CA inhibitors.Keywords
This publication has 38 references indexed in Scilit:
- Redesigning oxazolidinones as carbonic anhydrase inhibitors against vancomycin-resistant enterococciEuropean Journal of Medicinal Chemistry, 2025
- Exploring aliphatic sulfonamides as multiclass inhibitors of the carbonic anhydrases from the pathogen bacterium Vibrio choleraeArchiv der Pharmazie, 2024
- Overview on bacterial carbonic anhydrase genetic families2024
- Antimicrobial resistance: Impacts, challenges, and future prospectsJournal of Medicine, Surgery, and Public Health, 2024
- In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infectionMicrobial Pathogenesis, 2022
- Structural Mapping of Anion Inhibitors to β‐Carbonic Anhydrase psCA3 from Pseudomonas aeruginosaChemMedChem, 2018
- Evolving medicinal chemistry strategies in antibiotic discoveryCurrent Opinion in Biotechnology, 2016
- Targeting Bacterial Central Metabolism for Drug DevelopmentChemistry & Biology, 2014
- Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agentEuropean Journal of Medicinal Chemistry, 2011
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004